The relationships between ALKBH5, FTO genes variations and multiple clinical manifestations of PTB patients, including fever, drug resistance, DILI, pulmonary infection, hypoproteinemia, leukopenia, sputum smear-positive, were analyzed and listed in Table S2. This evidence concerns the gene ALKBH5 and Decreased total leukocyte count.